Published in Blood Weekly, June 15th, 2000
Such results were reported in a paper presented at a conference of leading medical scientists meeting in San Diego, California. The side effects are part of graft versus host disease (GvHD), an undesirable immune response mounted against an individual receiving a bone marrow stem cell transplant. This disease can occasionally lead to death. There is currently no effective...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.